✦ LIBER ✦

Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results

✍ Scribed by Shunji Takahashi, Takuji Iwase, Norio Kohno, Takashi Ishikawa, Tetsuya Taguchi, Masato Takahashi, Jun Horiguchi, Seigo Nakamura, Yasuo Hozumi, Masao Fukunaga, Shinzaburo Noguchi

Book ID: 113062424
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 337 KB
Volume: 133
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-1973-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

4–49 Zoledronic Acid Inhibits Adjuvant L

4–49 Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Zoledronic Acid Effectively Prevents Aro

Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

✍ Adam M. Brufsky; Linda D. Bosserman; Richard R. Caradonna; Barbara B. Haley; C. 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 151 KB

Effective inhibition of aromatase inhibi

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole : ZO-FAST study results

✍ Nigel J. Bundred; Ian D. Campbell; Neville Davidson; Richard H. DeBoer; Holger E 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Abstract ## BACKGROUND. Letrozole is safe and effective in postmenopausal women with estrogen receptor‐positive early breast cancer, but long‐term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection the

PCN67 Cost Effectiveness of Zoledronic A

PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian Perspectives

✍ Xue, M.; Fishman, P.; Botteman, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB